Health analysis for MapleMyst Rocketman

Generations:

Please note: If no health information is shown for an animal, this does not necessarily mean that the animal is healthy but merely that no information was provided.

MapleMyst Rocketman CAN 2019, COI 4.87 % * Breed relevant health information: Canine Multifocal Retinopathy 3 (CMR3) N/N (clear) - Clear by parentage Degenerative myelopathy (DM) N/N (clear) - Clear by parentage Glycogen storage disease type II (Pompe disease) (GSDII) N/N (clear) - Clear by parentage Progressive retinal atrophy (prcd-PRA) N/N (clear) - Clear by parentage	Sugarok Field of Dreams USA 2016, COI 3.86 % * Breed relevant health information: Canine Multifocal Retinopathy 3 (CMR3) N/N (clear) - 19/3/2018 Degenerative myelopathy (DM) N/N (clear) - 5/6/2017 Elbows normal - 12/1/2019 Glycogen storage disease type II (Pompe disease) (GSDII) N/N (clear) - 19/3/2018 Hips Good / A2 / 1-3 / A / 5-10 (no >6/hip) - 12/1/2019 Progressive retinal atrophy (prcd-PRA) N/N (clear) - 5/6/2017 Other health issues and screening results: Patella normal - 12/1/2019 Hyperuricosuria and Hyperuricemia (HUU, SLC) - 19/3/2018	Lecibsin Tanner FIN 2013, COI 4.94 % * Breed relevant health information: Hips Good / A2 / 1-3 / A / 5-10 (no >6/hip) - 5/8/2014	Lecibsin Harto FIN 2007, COI 6.04 % * Breed relevant health information: Glycogen storage disease type II (Pompe disease) (GSDII) N/N (clear) - Hips Excellent / A1 / 0 / A / 0-4 (no >3/hip) - Progressive retinal atrophy (prcd-PRA) N/N (clear) - Year of death: 2018
			Famskin Täpinä FIN 2009, COI 2.17 % * Breed relevant health information: Hips Fair / B1 / 4-6 / B / 11-18 - 16/9/2011
		Lecibsin Simasuu FIN 2011, COI 1.21 % *	Lecibsin Häätö FIN 1997, COI 4.39 % * Year of death: 2012
		Lecibsin Simasuu FIN 2011, COI 1.21 % *	Lecibsin Sakariini FIN 2006, COI 3.60 % *
	Sugarok Starfyre Glory Days USA 2015, COI 5.73 % * Breed relevant health information: Canine Multifocal Retinopathy 3 (CMR3) N/N (clear) - clear by parentage Degenerative myelopathy (DM) N/N (clear) - 9/11/2017 Glycogen storage disease type II (Pompe disease) (GSDII) N/N (clear) - clear by parentage Hips Good / A2 / 1-3 / A / 5-10 (no >6/hip) - 18/1/2018 Progressive retinal atrophy (prcd-PRA) N/N (clear) - clear by parentage Other health issues and screening results: Patella normal - 18/1/2018	Sugarok Born in the USA USA 2007, COI 4.31 % * Breed relevant health information: Hips Good / A2 / 1-3 / A / 5-10 (no >6/hip) - 9/10/2009	Janmanin Aleksanteri FIN 1998, COI 4.39 % * Breed relevant health information: Hips Good / A2 / 1-3 / A / 5-10 (no >6/hip) - 14/5/2007 Year of death: 2014
			Viksalan Noaidi FIN 2003, COI 4.91 % *
		Sugarok Dolley Madison USA 2013, COI 13.26 % * Breed relevant health information: Hips Good / A2 / 1-3 / A / 5-10 (no >6/hip) - 13/3/2015	Sugarok Nathan B Forrest USA 2011, COI 1.29 % Breed relevant health information: Elbows normal - 5/6/2013 Hips Good / A2 / 1-3 / A / 5-10 (no >6/hip) - 5/6/2013
			Sugarok Champagne on Ice USA 2009, COI 1.55 % * Breed relevant health information: Canine Multifocal Retinopathy 3 (CMR3) N/N (clear) - 21/3/2016 Degenerative myelopathy (DM) N/N (clear) - 21/3/2016 Elbows normal - 16/8/2011 Glycogen storage disease type II (Pompe disease) (GSDII) N/N (clear) - 16/3/2016 Hips Excellent / A1 / 0 / A / 0-4 (no >3/hip) - 16/8/2011 Progressive retinal atrophy (prcd-PRA) N/N (clear) - 21/3/2016

* COI cannot be reliably calculated due to incomplete generations in the pedigree!

Pedigree generated by breedarchive.com at 1/4/2025

The information on this page shows a snap-shot of the relevant data available in The Breed Archive at the time the page was created, with no guarantee with regard to the completeness or correctness of the data (the data having been provided by the user community). The Breed Archive accepts no liability with respect to the information shown or any conclusions drawn from it.

	Date of birth	Year of death	Canine Multifocal Retinopathy 3 (CMR3)	Degenerative myelopathy (DM)	Elbows	Glycogen storage disease type II (Pompe disease) (GSDII)	Hips	Progressive retinal atrophy (prcd-PRA)	Result of general cardiovascular health checks
Parents
Sugarok Starfyre Glory Days	11 Oct 2015	0 (null yrs)	N/N (clear)	N/N (clear)		N/N (clear)	Good / A2 / 1-3 / A / 5-10 (no >6/hip)	N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear) Degenerative myelopathy (DM): N/N (clear) Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear) Hips: Good / A2 / 1-3 / A / 5-10 (no >6/hip) Progressive retinal atrophy (prcd-PRA): N/N (clear)
Sugarok Field of Dreams	28 Oct 2016	0 (null yrs)	N/N (clear)	N/N (clear)	normal	N/N (clear)	Good / A2 / 1-3 / A / 5-10 (no >6/hip)	N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear) Degenerative myelopathy (DM): N/N (clear) Elbows: normal Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear) Hips: Good / A2 / 1-3 / A / 5-10 (no >6/hip) Progressive retinal atrophy (prcd-PRA): N/N (clear)
Siblings
MapleMyst's All that Glitters	19 May 2019	0 (null yrs)	N/N (clear)	N/N (clear)		N/N (clear)		N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear) Degenerative myelopathy (DM): N/N (clear) Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear) Progressive retinal atrophy (prcd-PRA): N/N (clear)
MapleMyst's Blame it on Midnight	19 May 2019	0 (null yrs)	N/N (clear)	N/N (clear)		N/N (clear)		N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear) Degenerative myelopathy (DM): N/N (clear) Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear) Progressive retinal atrophy (prcd-PRA): N/N (clear)
MapleMyst's I Can't Wait	19 May 2019	0 (null yrs)	N/N (clear)	N/N (clear)		N/N (clear)		N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear) Degenerative myelopathy (DM): N/N (clear) Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear) Progressive retinal atrophy (prcd-PRA): N/N (clear)
MapleMyst's Queen of the Night	19 May 2019	0 (null yrs)	N/N (clear)	N/N (clear)		N/N (clear)		N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear) Degenerative myelopathy (DM): N/N (clear) Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear) Progressive retinal atrophy (prcd-PRA): N/N (clear)
MapleMyst's Simply the Best	19 May 2019	0 (null yrs)	N/N (clear)	N/N (clear)		N/N (clear)		N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear) Degenerative myelopathy (DM): N/N (clear) Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear) Progressive retinal atrophy (prcd-PRA): N/N (clear)
MapleMyst's Sweet Pup o'Mine	19 May 2019	0 (null yrs)	N/N (clear)	N/N (clear)		N/N (clear)		N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear) Degenerative myelopathy (DM): N/N (clear) Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear) Progressive retinal atrophy (prcd-PRA): N/N (clear)
Half siblings (sire)
MapleMyst Bold with a Smooth Finnish	29 Sep 2020	0 (null yrs)	N/N (clear)	N/N (clear)	normal	N/N (clear)	Good / A2 / 1-3 / A / 5-10 (no >6/hip)	N/N (clear)	OK
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear) Degenerative myelopathy (DM): N/N (clear) Elbows: normal Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear) Hips: Good / A2 / 1-3 / A / 5-10 (no >6/hip) Progressive retinal atrophy (prcd-PRA): N/N (clear) Result of general cardiovascular health checks: OK
MapleMyst Fellowship of the Drink	29 Sep 2020	0 (null yrs)	N/N (clear)	N/N (clear)		N/N (clear)		N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear) Degenerative myelopathy (DM): N/N (clear) Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear) Progressive retinal atrophy (prcd-PRA): N/N (clear)
MapleMyst's Fur Bodied	29 Sep 2020	0 (null yrs)	N/N (clear)	N/N (clear)		N/N (clear)		N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear) Degenerative myelopathy (DM): N/N (clear) Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear) Progressive retinal atrophy (prcd-PRA): N/N (clear)
MapleMyst's Little Brown Jug	29 Sep 2020	0 (null yrs)	N/N (clear)	N/N (clear)		N/N (clear)		N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear) Degenerative myelopathy (DM): N/N (clear) Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear) Progressive retinal atrophy (prcd-PRA): N/N (clear)
MapleMyst's Mouton Ridge	29 Sep 2020	0 (null yrs)	N/N (clear)	N/N (clear)		N/N (clear)		N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear) Degenerative myelopathy (DM): N/N (clear) Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear) Progressive retinal atrophy (prcd-PRA): N/N (clear)
MapleMyst's On Cloud Wine	29 Sep 2020	0 (null yrs)	N/N (clear)	N/N (clear)		N/N (clear)		N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear) Degenerative myelopathy (DM): N/N (clear) Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear) Progressive retinal atrophy (prcd-PRA): N/N (clear)
MapleMyst's Rosé	29 Sep 2020	0 (null yrs)	N/N (clear)	N/N (clear)		N/N (clear)		N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear) Degenerative myelopathy (DM): N/N (clear) Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear) Progressive retinal atrophy (prcd-PRA): N/N (clear)
MapleMyst's Sippin' Pretty	29 Sep 2020	0 (null yrs)	N/N (clear)	N/N (clear)		N/N (clear)		N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear) Degenerative myelopathy (DM): N/N (clear) Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear) Progressive retinal atrophy (prcd-PRA): N/N (clear)
Half siblings (dam)
Offspring